Something's up..., page-31

I think Benitec will be under the gun to provide robust AMD results at the same time TT-034 results come out. That's because if TT-034 results are sub-par, they'll have AMD to soften the blow. But if history is any clue, positive news on preclinical applications have not provided the sp with any lasting value. We need both to have positivity to give any credence to proving more funding....once again. All in my opinion, of course.